Geneception
Skyline Therapeutics – A fully-integrated gene therapy company.
Shanghai, China · Founded 2019 · $150.0M raised
- Headquarters
- Shanghai
- Employees
- 11–50
- Founded
- 2019
- Business Model
- B2B
- Website
- skytx.com
- Total Funding
- $150.0M
- Last Round
- $150.0M Series AJan 2019
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 4 investors for this company. The full record is or through the API.
About
Geneception was a fully integrated gene and cell therapy company founded in 2019 and headquartered in Hangzhou and Shanghai, China. Backed by F-Prime Capital and Eight Roads Ventures China, the company was dedicated to the discovery, development, and delivery of innovative gene therapies for unmet medical needs. In 2020, Geneception rebranded as Skyline Therapeutics and has since expanded its pipeline to include cardiovascular gene therapy programs, including a strategic collaboration with BioMarin, and established an R&D center in Zhangjiang Science City.
Summary
Geneception is a Biotech company based in Shanghai, China, founded in 2019. It has raised $150.0M in total across 1 round, most recently a $150.0M Series A round in Jan 2019. Investors include Hillhouse Capital, Sequoia Capital and ARCH Venture Partners.
Funding History
2019 (est.)
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/geneception"><img src="https://indexed.vc/api/badge/company/geneception" alt="Geneception on Indexed.vc" width="260" height="76" /></a>